AveXis Inc buy melinda
Start price
28.02.18
/
50%
€108.41
Target price
12.03.18
€128.99
Performance (%)
14.74%
End price
12.03.18
€124.39
Summary
This prediction ended on 12.03.18 with a price of €124.39. The prediction had a final performance of 14.74%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
AveXis Inc | - | - | - | - |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by melinda for this prediction
In the thread AveXis Inc diskutieren
Geschäft mit Therapien auf Basis von Nukleinsäure-Targeting monogenen Erkrankungen des ZNS
Sektor
Biotechnologie und medizinische Forschung
(Vom Mitglied beendet)